Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy

Blood (2019) 134 (Supplement_1): 185.

https://doi.org/10.1182/blood-2019-131390

Published: 2019

Journal Articles

Mitochondrial Fission 1 Regulates GSK3 and AMPK Signaling to Sustain Leukemia Stem Cell Function in Acute Myelogenous Leukemia

Shanshan Pei, PhD, Mohammad Minhajuddin, PhD, Biniam Adane, BS, Brett M Stevens, PhD, Nabilah Khan, PhD, Angelo D'alessandro, PhD, Travis Nemkov, Kirk C Hansen, PhD, Daniel A Pollyea, MD, Craig T Jordan, PhD

Blood (2016) 128 (22): 1703.

https://doi.org/10.1182/blood.V128.22.1703.1703

Published: 2016

Journal Articles

The Role of NADPH Oxidase 2 in Normal and Malignant Hematopoiesis

Biniam Adane, BS, Haobin Ye, PhD, Shanshan Pei, PhD, Nabilah Khan, PhD, Mohammad Minhajuddin, PhD, Brett M Stevens, PhD, Vadym Zaberezhnyy, Daniel A Pollyea, MD, Craig T Jordan, PhD

Blood (2016) 128 (22): 1079.

https://doi.org/10.1182/blood.V128.22.1079.1079

Published: 2016

Journal Articles

Adipose Tissue-Derived IGFBP1 Facilitates Progression of Leukemia

Haobin Ye, PhD, Nabilah Khan, PhD, Mohammad Minhajuddin, PhD, Biniam Adane, BS, Craig T Jordan, PhD

Blood (2016) 128 (22): 3058.

https://doi.org/10.1182/blood.V128.22.3058.3058

Published: 2016

Journal Articles

Regulation of Mitochondrial Morphology Is Important for Leukemia Stem Cell Function

Shanshan Pei, PhD, Mohammad Minhajuddin, PhD, Brett M Stevens, PhD, Biniam Adane, Nabilah Khan, PhD, Angelo D'alessandro, PhD, Travis Nemkov, Kirk C Hansen, PhD, Daniel Pollyea, MD MS, Craig T Jordan, PhD

Blood (2015) 126 (23): 842.

https://doi.org/10.1182/blood.V126.23.842.842

Published: 2015

Journal Articles

Aldehyde Dehydrogenases Play a Role in Acute Myeloid Leukemia and Have Prognostic and Therapeutic Significance

Maura Gasparetto, MD, Shanshan Pei, PhD, Mohammad Minhajuddin, PhD, Daniel A. Pollyea, MD MS, Vasilis Vasiliou, PhD, R. Keith Humphries, MD PhD, Craig T. Jordan, PhD, Clayton A. Smith, MD FRCPC

Blood (2014) 124 (21): 2238.

https://doi.org/10.1182/blood.V124.21.2238.2238

Published: 2014

Journal Articles

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Jane L. Liesveld, MD, Kristen O'Dwyer, MD, Michael W. Becker, MD, Deborah Mulford, MD, Alison Walker, MD, Rui Chen, PhD, Jeremy Bechelli, MS, Karen Rosell, BS, Craig T. Jordan, PhD, Mohammad Minhajuddin, PhD, Gordon L. Phillips, II, MD

Blood (2012) 120 (21): 3549.

https://doi.org/10.1182/blood.V120.21.3549.3549

Published: 2012

Journal Articles

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Kevin P Callahan, PhD, Cheryl Corbett, Steven Jacob, Mohammad Minhajuddin, PhD, Eleni D Lagadinou, MD/PhD, Randall M Rossi, MS, Valerie Gross, Marlene Balys, Fred Hagen, PhD, Alison J Frontier, PhD, Craig T. Jordan, PhD

Blood (2012) 120 (21): 1338.

https://doi.org/10.1182/blood.V120.21.1338.1338

Published: 2012

Journal Articles

Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting

Eleni Lagadinou, MD/PhD, Kevin Callahan, PhD, Sarah J Neering, BS, ShanShan Pei, BS, Mohammad Minhajuddin, PhD, Randall M Rossi, MS, Valerie Grose, BS, Cheryl Corbett, Marlene Balys, BS, Paul Brookes, PhD, Craig T. Jordan, PhD

Blood (2011) 118 (21): 639.

https://doi.org/10.1182/blood.V118.21.639.639

Published: 2011

Journal Articles

Molecular Mechanisms of Parthenolide-Mediated Pro-Apoptotic Activity in Acute Myeloid Leukemia Cells

Mohammad Minhajuddin, PhD, Shanshan Pei, John M Ashton, Kevin Callahan, PhD, Eleni Lagadinou, MD/PhD, Marlene Balys, Cheryl Corbett, Sarah Neering, Randall M Rossi, MS, Craig T. Jordan, PhD

Blood (2011) 118 (21): 2463.

https://doi.org/10.1182/blood.V118.21.2463.2463

Published: 2011

Journal Articles

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

Shanshan Pei, Kevin Callahan, PhD, Mohammad Minhajuddin, PhD, Marlene Balys, Sarah Neering, Cheryl Corbett, Michael W. Becker, MD, Jane L. Liesveld, MD, Fred Hagen, PhD, Alan E Friedman, PhD, Peter Crooks, PhD, Craig T. Jordan, PhD

Blood (2011) 118 (21): 3506.

https://doi.org/10.1182/blood.V118.21.3506.3506

Published: 2011

NARROW

Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy

Mitochondrial Fission 1 Regulates GSK3 and AMPK Signaling to Sustain Leukemia Stem Cell Function in Acute Myelogenous Leukemia

The Role of NADPH Oxidase 2 in Normal and Malignant Hematopoiesis

Adipose Tissue-Derived IGFBP1 Facilitates Progression of Leukemia

Regulation of Mitochondrial Morphology Is Important for Leukemia Stem Cell Function

Aldehyde Dehydrogenases Play a Role in Acute Myeloid Leukemia and Have Prognostic and Therapeutic Significance

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting

Molecular Mechanisms of Parthenolide-Mediated Pro-Apoptotic Activity in Acute Myeloid Leukemia Cells

Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only